UBS Group’s Rosecliff Acquisition Corp I Unit RCLFU Stock Holding History

UBS Group’s Portfolio RCLFU Stock Details RCLFU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-300	Closed	-$3.2K	–	10256
2023 Q2	$3.2K	Buy	+300	New	+$3.29K	﹤0.01%	7656
2023 Q1	–	Sell	-685	Closed	-$7K	–	11049
2022 Q4	$7K	Hold	685	–	–	﹤0.01%	8952
2022 Q3	$7K	Buy	685 +100	+17%	+$985	﹤0.01%	8945
2022 Q2	$6K	Hold	585	–	–	﹤0.01%	8778
2022 Q1	$6K	Sell	585 -1,300	-69%	-$12.9K	﹤0.01%	9034
2021 Q4	$19K	Buy	1,885 +655	+53%	+$6.58K	﹤0.01%	7933
2021 Q3	$12K	Sell	1,230 -1,856	-60%	-$18.4K	﹤0.01%	7817
2021 Q2	$31K	Sell	3,086 -1,612	-34%	-$16K	﹤0.01%	6905
2021 Q1	$47K	Buy	+4,698	New	+$47.3K	﹤0.01%	6637

UBS Group's RCLFU Position: Q3 2023 in Review

UBS Group sold out of Rosecliff Acquisition Corp I Unit (RCLFU) in Q3 2023, closing a stake of 300 shares — an estimated $3.2K sold.

UBS Group first reported a position in RCLFU in Q1 2021 and held it in 9 quarters. The position peaked at $47K in Q1 2021. 0 funds tracked by Wall St. Rank hold RCLFU as of Q3 2023.

UBS Group reported no remaining Rosecliff Acquisition Corp I Unit position as of Q3 2023 after selling out during the quarter.
UBS Group sold 300 Rosecliff Acquisition Corp I Unit shares in Q3 2023, an estimated $3.2K.
UBS Group first reported a position in Rosecliff Acquisition Corp I Unit in Q1 2021 and held it in 9 quarters.
UBS Group's Rosecliff Acquisition Corp I Unit position peaked at $47K in Q1 2021.
0 funds tracked by Wall St. Rank held Rosecliff Acquisition Corp I Unit as of Q3 2023.

Based on UBS Group's 13F filing for Q3 2023, filed 9 Nov 2023.